Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction

  • Fernandez-Berges, D.
  • Degano, I.R.
  • Fernandez, R.G.
  • Subirana, I.
  • Vila, J.
  • Jimenez-Navarro, M.
  • Perez-Fernandez, S.
  • Roque, M.
  • Bayes-Genis, A.
  • Fernandez-Aviles, F.
  • Mayorga, A.
  • Bertomeu-Gonzalez, V.
  • Sanchis, J.
  • Esteban, M.R.
  • Sanchez-Hidalgo, A.
  • Sanchez-Insa, E.
  • Elorriaga, A.
  • Abu Assi, E.
  • Nunez, A.
  • Ruiz, J.M.G.
  • Valdeolmillos, P.M.
  • Bosch-Portell, D.
  • Lekuona, I.
  • Carrillo-Lopez, A.
  • Zamora, A.
  • Vega-Hernandez, B.
  • Serrano, J.A.
  • Rubert, C.
  • Ruiz-Valdepenas, L.
  • Quintas, L.
  • Rodriguez-Padial, L.
  • Vaquero, J.
  • Martinez Dolz, L.
  • Barrabes, J.A.
  • Sanchez, P.L.
  • Sionis, A.
  • Marti-Almor, J.
  • Elosua, R.
  • Lidon, R.M.
  • Garcia-Dorado, D.
  • Marrugat, J.
Objective: Primary percutaneous coronary intervention (P-PCI) has demonstrated its efficacy in patients with ST segment elevation myocardial infarction (STEMI). However, patients with STEMI >= 75 years receive less P-PCI than younger patients despite their higher in-hospital morbimortality. The objective of this analysis was to determine the effectiveness of P-PCI in patients with STEMI >= 75 years. Methods: We included 979 patients with STEMI >= 75 years, from the ATencion HOspitalaria del Sindrome coronario study, a registry of 8142 consecutive patients with acute coronary syndrome admitted at 31 Spanish hospitals in 2014-2016. We calculated a propensity score (PS) for the indication of P-PCI. Patients that received or not P-PCI were matched by PS. Using logistic regression, we compared the effectiveness of performing P-PCI versus non-performance for the composite primary event, which included death, reinfarction, acute pulmonary oedema or cardiogenic shock during hospitalisation. Results: Of the included patients, 81.5 % received P-PCI. The matching provided two groups of 169 patients with and without P-PCI. Compared with its non-performance, P-PCI presented a composite event OR adjusted by PS of 0.55 (95% CI 0.34 to 0.89). Conclusions: Receiving a P-PCI was significantly associated with a reduced risk of major intrahospital complications in patients with STEMI aged 75 years or older.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Impact of implementing electronic clinical practice guidelines for the diagnosis, control and treatment of cardiovascular risk factors, A pre-post controlled study

  • Comín, Eva
  • Catalán-Ramos, Arantxa
  • Iglesias-Rodal, Manuel
  • Grau, Maria|||0000-0003-2807-8136
  • Del Val García, José Luis|||0000-0002-0391-9368
  • Consola, Alicia
  • Amado, Ester
  • Pons, Angels
  • Mata-Cases, Manel|||0000-0003-3693-3622
  • Franzi Sisó, Alícia
  • Frigola-Capell, Eva|||0000-0003-4758-0316
  • Cos Claramunt, Francesc Xavier|||0000-0003-3943-479X
  • Davins Miralles, Josep
  • Verdú Rotellar, Jose María|||0000-0003-4225-8504
To evaluate the impact of computerized clinical practice guidelines on the management, diagnosis, treatment, control, and follow-up of the main cardiovascular risk factors: hypertension, hypercholesterolaemia, and type 2 diabetes mellitus. Pre-post controlled study. Catalonia, autonomous community located in north-eastern Spain. Individuals aged 35-74 years assigned to general practitioners of the Catalan Health Institute. The intervention group consisted of individuals whose general practitioners had accessed the computerized clinical practice guidelines at least twice a day, while the control group consisted of individuals whose general practitioner had never accessed the computerized clinical practice guidelines platform. The Chi-squared test was used to detect significant differences in the follow-up, control, and treatment variables for all three disorders (hypertension, hypercholesterolaemia, and type 2 diabetes mellitus) between individuals assigned to users and non-users of the computerized clinical practice guidelines, respectively. A total of 189,067 patients were included in this study, with a mean age of 56 years (standard deviation 12), and 55.5% of whom were women. Significant differences were observed in hypertension management, treatment and control; type 2 diabetes mellitus management, treatment and diagnoses, and the management and control of hypercholesterolaemia in both sexes. Computerized clinical practice guidelines are an effective tool for the control and follow-up of patients diagnosed with hypertension, type 2 diabetes mellitus, and hypercholesterolaemia. The usefulness of computerized clinical practice guidelines to diagnose and adequately treat individuals with these disorders remains unclear.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Association of circulating microRNAs with coronary artery disease and usefulness for reclassification of healthy individuals, The REGICOR study

  • Degano, Irene R.|||0000-0003-1914-6934
  • Camps-Vilaró, Anna|||0000-0001-9644-8421
  • Subirana, Isaac|||0000-0003-1676-0197
  • García-Mateo, Nadia
  • Cidad, Pilar
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Puigdecanet, Eulàlia|||0000-0001-6067-9332
  • Nonell, Lara|||0000-0002-8538-8213
  • Vila-Domènech, Joan Salvador|||0000-0002-0413-9291
  • Crepaldi, Felipe Mingorance|||0000-0002-8500-1162
  • Gonzalo Calvo, David de|||0000-0003-2240-3532
  • Llorente-Cortés, Vicenta|||0000-0002-0067-7201
  • Pérez-García, María Teresa|||0000-0001-8540-8117
  • Elosua, Roberto|||0000-0001-8235-0095
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Marrugat, Jaume|||0000-0003-3320-554X
Risk prediction tools cannot identify most individuals at high coronary artery disease (CAD) risk. Oxidized low-density lipoproteins (oxLDLs) and microRNAs are actively involved in atherosclerosis. Our aim was to examine the association of CAD and oxLDLs-induced microRNAs, and to assess the microRNAs predictive capacity of future CAD events. Human endothelial and vascular smooth muscle cells were treated with oxidized/native low-density lipoproteins, and microRNA expression was analyzed. Differentially expressed and CAD-related miRNAs were examined in serum samples from (1) a case-control study with 476 myocardial infarction (MI) patients and 487 controls, and (2) a case-cohort study with 105 incident CAD cases and 455 randomly-selected cohort participants. MicroRNA expression was analyzed with custom OpenArray plates, log rank tests and Cox regression models. Twenty-one microRNAs, two previously undescribed (hsa-miR-193b-5p and hsa-miR-1229-5p), were up- or down-regulated upon cell treatment with oxLDLs. One of the 21, hsa-miR-122-5p, was also upregulated in MI cases (fold change = 4.85). Of the 28 CAD-related microRNAs tested, 11 were upregulated in MI cases -1 previously undescribed (hsa-miR-16-5p)-, and 1/11 was also associated with CAD incidence (adjusted hazard ratio = 0.55 (0.35-0.88)) and improved CAD risk reclassification, hsa-miR-143-3p. We identified 2 novel microRNAs modulated by oxLDLs in endothelial cells, 1 novel microRNA upregulated in AMI cases compared to controls, and one circulating microRNA that improved CAD risk classification.